Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeOnc Technologies Holdings, Inc. - Common Stock (NQ:NTHI)

8.306 -0.694 (-7.72%)
Streaming Delayed Price Updated: 12:38 PM EDT, Oct 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 22,283
Open 9.235
Bid (Size) 8.130 (1)
Ask (Size) 8.400 (16)
Prev. Close 9.000
Today's Range 8.306 - 9.235
52wk Range 3.200 - 25.00
Shares Outstanding 19,159,118
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Meet the Companies - New to The Street's Accredited Investor Event Returns October 21-22 at Hudson Yards, NYC
Via ACCESS Newswire
NeOnc Technologies' Subsidiary, NuroMENA, Signs Master Services Agreement with M42’s IROS and Expands Board of Directors
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire

Performance

YTD
-31.4%
-31.4%
1 Month
-30.4%
-30.4%
3 Month
+67.8%
+67.8%
6 Month
+41.3%
+41.3%
1 Year
-31.4%
-31.4%

More News

Read More
New to The Street to Broadcast Tonight on Fox Business 10:30 PM PST Featuring NeOnc Technologies, FLOKI, XION, Sharps Technology, and Aeries Technology
Via ACCESS Newswire
NeOnc Technologies and Quazar Investment Set to Close $50 Million Strategic Partnership by October 23rd Following Final UAE Tax Approvals
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
NeOnc Technologies Appoints Dr. David M. Ashley, Director of The Preston Robert Tisch Brain Tumor Center at Duke, to Scientific Advisory Board
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
NeOnc Technologies Welcomes Dr. Alexandra M. Miller, Chief of Neuro-Oncology and Co-Director of the Brain and Spine Tumor Center at NYU Langone Health’s Perlmutter Cancer Center, to Its Scientific Advisory Board
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
NeOnc Technologies Appoints Renowned Neuro-Oncologist Dr. Henry S. Friedman to Scientific Advisory Board
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
New to The Street to Broadcast Saturday, September 27th Featuring NeOnc Pharma $NTHI and Other Innovative Companies
Via ACCESS Newswire
NeOnc Technologies to Showcase Progress on Addressing Brain Cancer to 63 Million TV Households on “Health Uncensored with Dr. Drew” on the Lifetime Network on September 25, premiering nationwide at 8:00 a.m. ET/PT
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
New to The Street to Broadcast Episode 686 Tonight on Bloomberg Television at 6:30 PM EST
Via ACCESS Newswire
NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 – A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
NeOnc Technologies Closes Strategic Acquisition of Advanced AI and 3D Bioprinting IP, Appointing World-Renowned Scientist Dr. Ishwar K. Puri to its Board
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
NeOnc Technologies Holdings Reports Second Quarter 2025 Results and Provides Operational Update
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
New to The Street's Esteemed Client NeOnc Technologies Finalizes $50 Million Strategic Partnership with Quazar Investment as NuroMENA Holdings Receives ADGM Incorporation
Via ACCESS Newswire
NeOnc Technologies Finalizes All Contingencies for $50 Million Strategic Partnership with Quazar Investment as NuroMENA Holdings Receives ADGM Incorporation
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
NeOnc Technologies Awarded $2.5 Million in NIH STTR Grants to Advance NEO212 in Gliomas and Leukemia
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
NeOnc Technologies Featured on Yahoo Finance's Podcast Trader Talk: AI and Biotech Take on Brain Cancer
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
New to The Street Signs NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) to 12-Part National Broadcast Series Including T.V. Network Features, Earned Media, Commercials, and Iconic Outdoor Billboards
Via ACCESS Newswire
NeOnc Technologies Signs Definitive Agreement to Acquire AI, 3D, and Quantum Modeling IP Portfolio from Dr. Ishwar K. Puri; Appoints Him to Board of Directors
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
What's going on in today's after hours session
Via Chartmill
NeOnc Technologies Signs Definitive Agreement for $50 Million Strategic Partnership with Quazar Investment
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
NeOnc Technologies to Participate at the BTIG Virtual Biotechnology Conference
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
CORRECTING and REPLACING - NeOnc Technologies Holdings, Inc.
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is NeOnc Technologies Holdings, Inc. - Common Stock publicly traded?
Yes, NeOnc Technologies Holdings, Inc. - Common Stock is publicly traded.
What exchange does NeOnc Technologies Holdings, Inc. - Common Stock trade on?
NeOnc Technologies Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeOnc Technologies Holdings, Inc. - Common Stock?
The ticker symbol for NeOnc Technologies Holdings, Inc. - Common Stock is NTHI on the Nasdaq Stock Market
What is the current price of NeOnc Technologies Holdings, Inc. - Common Stock?
The current price of NeOnc Technologies Holdings, Inc. - Common Stock is 8.306
When was NeOnc Technologies Holdings, Inc. - Common Stock last traded?
The last trade of NeOnc Technologies Holdings, Inc. - Common Stock was at 10/23/25 12:38 PM ET
What is the market capitalization of NeOnc Technologies Holdings, Inc. - Common Stock?
The market capitalization of NeOnc Technologies Holdings, Inc. - Common Stock is 159.13M
How many shares of NeOnc Technologies Holdings, Inc. - Common Stock are outstanding?
NeOnc Technologies Holdings, Inc. - Common Stock has 159M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.